Nice find, do you have the url link to check it out their...

Nice find, do you have the url link to check it out their page?
It May mean they don't want to talk to CROs or market access companies, etc trying to win work. But who knows, maybe their getting a lot of interest and only want to spend time with key players.

I get the feeling Stamler likes all his ducks in a row before properly commencing partnering talk, i.e. JPM was too early. But now could be a good time to actually see what big pharma could offer in terms of partnership/buyout. Would have to be very attractive considering the recent big dilution giving us the resources to get to market for MSA, hopefully they keep that in mind.